carbostyril has been researched along with bictegravir in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Burger, DM; Colbers, A; Greupink, R; Schalkwijk, SJ; Ter Heine, R; van der Galiën, R; van Herwaarden, AE | 1 |
| Anstett, K; Brenner, BG; Ibanescu, RI; Mésplède, T; Oliveira, M; Robbins, MA; Routy, JP | 1 |
| Álvarez, H; Llibre, JM; Yzusqui, M | 1 |
| Byland, E; Canupp, K; Dunlap, J; Mospan, C; Mospan, G; Whitaker, WB; Xiong, L | 1 |
| Abram, ME; Callebaut, C; Margot, NA; Ram, RR; White, KL | 1 |
| Chen, SQ; Li, Q; Yang, LL; Zhou, LB | 1 |
| Albanesi, E; Appendino, A; Boccuto, A; Dragoni, F; Giannini, A; Saladini, F; Vicenti, I; Zazzi, M | 1 |
| Castagna, A; Fornabaio, C; Galli, L; Malena, M; Menozzi, M; Poli, A; Santoro, MM; White, KL; Zazzi, M | 1 |
| Cloete, R; Ikomey, GM; Isaacs, D; Jacobs, GB; Mikasi, SG; Obasa, AE; Shityakov, S | 1 |
| Chimukangara, B; Gordon, M; Mbhele, N | 1 |
| Calcagno, A; Calza, S; Castelli, F; Cattelan, AM; Celesia, BM; Chiesa, A; De Socio, G; Ferrara, M; Focà, E; Guaraldi, G; Madeddu, G; Milic, J; Nozza, S; Orofino, G; Piconi, S; Renzetti, S; Siano, M | 1 |
4 review(s) available for carbostyril and bictegravir
| Article | Year |
|---|---|
Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps.
Topics: Amides; Anti-Retroviral Agents; Female; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Infectious Disease Transmission, Vertical; Knowledge; Oxazines; Piperazines; Pregnancy; Pyridones; Quinolones; Raltegravir Potassium | 2019 |
Clinical Impact of Virological Failure and Resistance Analysis Definitions used in Pivotal Clinical Trials of Initial Antiretroviral Treatment: A Systematic Review
Topics: Amides; Anti-Retroviral Agents; Clinical Trials as Topic; Cobicistat; Darunavir; Drug Resistance, Viral; Genotype; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Oxazines; Piperazines; Pyridones; Quinolones; Rilpivirine; RNA, Viral; Triazoles; Viral Load | 2018 |
Meta-analysis and systematic review of the efficacy and resistance for human immunodeficiency virus type 1 integrase strand transfer inhibitors.
Topics: Amides; Drug Resistance, Viral; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Microbial Sensitivity Tests; Oxazines; Piperazines; Pyridones; Quinolones; Raltegravir Potassium; Virus Replication | 2019 |
HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance.
Topics: Amides; Anti-Retroviral Agents; Drug Resistance, Viral; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Oxazines; Piperazines; Pyridones; Quinolones; Raltegravir Potassium; Virus Replication | 2021 |
7 other study(ies) available for carbostyril and bictegravir
| Article | Year |
|---|---|
Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir.
Topics: Amides; Anti-HIV Agents; Drug Resistance, Viral; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Mutation; Oxazines; Piperazines; Pyridones; Quinolones; Virus Replication | 2018 |
Drug updates and approvals: 2018 in review.
Topics: Adenine; Alanine; Amides; Aminophenols; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzodioxoles; Clonidine; Doxylamine; Drug Approval; Emtricitabine; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Indoles; Piperazines; Pyridones; Pyridoxine; Quinolones; Tenofovir; United States; United States Food and Drug Administration | 2018 |
Antiviral activity of HIV-1 integrase strand-transfer inhibitors against mutants with integrase resistance-associated mutations and their frequency in treatment-naïve individuals.
Topics: Amides; Drug Resistance, Viral; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Mutation; Oxazines; Piperazines; Polymorphism, Genetic; Pyridones; Quinolones | 2019 |
Comparable
Topics: Amides; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Mutation; Oxazines; Piperazines; Pyridones; Quinolones; Raltegravir Potassium | 2019 |
Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen.
Topics: Amides; Drug Resistance, Multiple, Viral; Female; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Quinolones; Raltegravir Potassium; Treatment Outcome | 2020 |
Structural Comparison of Diverse HIV-1 Subtypes using Molecular Modelling and Docking Analyses of Integrase Inhibitors.
Topics: Amides; Binding Sites; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Linear Models; Models, Molecular; Molecular Docking Simulation; Oxazines; Piperazines; Pyridones; Quinolones; Raltegravir Potassium; Sequence Alignment | 2020 |
Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort.
Topics: Aged; Amides; Anti-Retroviral Agents; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Longitudinal Studies; Male; Medication Adherence; Oxazines; Piperazines; Polypharmacy; Proportional Hazards Models; Prospective Studies; Pyridones; Quinolones; Raltegravir Potassium; Treatment Outcome | 2021 |